EXPERIMENTAL BIOLOGY AND MEDICINE

Scope & Guideline

Fostering collaboration through cutting-edge research.

Introduction

Immerse yourself in the scholarly insights of EXPERIMENTAL BIOLOGY AND MEDICINE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1535-3702
PublisherFRONTIERS MEDIA SA
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1996 to 2024
AbbreviationEXP BIOL MED / Exp. Biol. Med.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND

Aims and Scopes

The journal 'Experimental Biology and Medicine' aims to publish high-quality research that advances the understanding of biological processes and their applications in medicine. It covers a broad range of topics, with a focus on experimental studies that bridge the gap between basic science and clinical practice.
  1. Translational Research:
    The journal emphasizes translational research that translates basic scientific discoveries into clinical applications, addressing health challenges and improving patient outcomes.
  2. Innovative Therapeutic Approaches:
    Research on novel therapeutic strategies, including drug development, gene therapy, and regenerative medicine, is a core focus, highlighting innovative methods to treat various diseases.
  3. Mechanistic Studies:
    Studies elucidating the underlying biological mechanisms of diseases, particularly at the molecular and cellular levels, are prominently featured to enhance understanding of pathophysiology.
  4. Systems Biology and Bioinformatics:
    The integration of systems biology and bioinformatics approaches is encouraged to analyze complex biological data, identify biomarkers, and predict therapeutic responses.
  5. Interdisciplinary Approaches:
    The journal promotes interdisciplinary research that combines insights from biology, medicine, engineering, and computational sciences to tackle complex health issues.
  6. Clinical and Experimental Studies:
    A balance of clinical and experimental studies is maintained, with a focus on the application of experimental findings to clinical settings.
Recent publications in 'Experimental Biology and Medicine' reveal several emerging trends and themes that reflect the evolving landscape of biomedical research. These trends indicate a shift towards more complex, integrative approaches to understanding health and disease.
  1. Precision Medicine:
    There is a significant increase in research focused on precision medicine, which tailors treatment strategies based on individual genetic, environmental, and lifestyle factors, enhancing therapeutic efficacy.
  2. Neuroinflammation and Neurological Disorders:
    Recent studies increasingly address the role of neuroinflammation in various neurological disorders, highlighting the importance of understanding immune responses in the central nervous system.
  3. Microbiome Research:
    Research exploring the role of the microbiome in health and disease is gaining traction, with studies investigating how gut flora influences metabolic processes, immune function, and disease susceptibility.
  4. Regenerative Medicine and Stem Cell Therapy:
    There is a rising interest in regenerative medicine, particularly the application of stem cell therapies for tissue repair and the treatment of degenerative diseases.
  5. Artificial Intelligence in Healthcare:
    The integration of artificial intelligence and machine learning techniques in biomedical research is emerging as a critical area, with applications ranging from drug discovery to personalized treatment plans.
  6. Immunotherapy and Cancer Research:
    Immunotherapy continues to be a major focus, with increasing research into novel immune-based therapies for cancer treatment and the mechanisms underlying immune evasion by tumors.

Declining or Waning

In recent years, several research themes appear to have lost prominence in 'Experimental Biology and Medicine'. This decline may reflect shifts in scientific priorities or advancements in other areas that overshadow previous interests.
  1. Traditional Pharmacology:
    Research focused solely on traditional pharmacological approaches is less popular, as the field increasingly shifts towards personalized medicine and targeted therapies.
  2. Basic Animal Models:
    While animal studies remain important, there is a noticeable decline in publications using basic animal models without translational relevance, as researchers seek more sophisticated models that better mimic human diseases.
  3. Single-Factor Studies:
    The trend towards studies examining single factors or variables in isolation is waning, with a growing preference for multi-factorial studies that consider complex interactions.
  4. In vitro Studies without Clinical Relevance:
    In vitro studies that do not connect to clinical implications or therapeutic applications are being published less frequently, as the journal emphasizes studies with direct relevance to human health.
  5. Epidemiological Studies without Molecular Insights:
    Epidemiological studies that lack molecular or mechanistic insights into the diseases studied are becoming less prominent, reflecting a preference for research that integrates population data with biological understanding.

Similar Journals

Journal of Extracellular Vesicles

Unraveling Cellular Communication Through Groundbreaking Research
Publisher: WILEYISSN: Frequency: 12 issues/year

Journal of Extracellular Vesicles, published by WILEY, stands at the forefront of research in the evolving fields of Cell Biology and Histology as a prestigious open-access journal that has been disseminating groundbreaking findings since 2012. With a commendable impact exemplified by its Q1 ranking in both categories for 2023, this journal offers an invaluable platform for researchers, professionals, and students to explore the critical roles of extracellular vesicles in cellular communication, disease pathology, and therapeutics. The journal is indexed in leading databases, ensuring wide visibility and accessibility of its content, which supports the collaborative spirit of scientific discovery. Featuring innovative research and comprehensive reviews, the Journal of Extracellular Vesicles not only maintains a high standard of scholarship but also fosters a community dedicated to advancing our understanding of these small yet significant cellular components.

Quantitative Biology

Transforming Biological Research with Mathematical Precision
Publisher: WILEYISSN: 2095-4689Frequency: 4 issues/year

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

Experimental and Therapeutic Medicine

Advancing discoveries in Immunology, Microbiology, and Cancer Research.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

Biomedical Research and Therapy

Advancing biomedical knowledge through innovative research.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Open Life Sciences

Championing Free Access to Life-Changing Research
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2391-5412Frequency: 1 issue/year

Open Life Sciences is a distinguished open-access journal published by DE GRUYTER POLAND SP Z O O, dedicated to advancing research across diverse disciplines in the life sciences. Since its inception in 2014 and transitioning to open access in 2015, the journal has become a pivotal platform for researchers, fostering the dissemination of high-quality scientific work while ensuring that valuable findings are freely accessible to the global community. With an impressive categorization into Q2 in Agricultural and Biological Sciences and Q3 in several other fields including Biochemistry and Immunology as of 2023, Open Life Sciences promotes innovation and knowledge sharing across its broad spectrum of topics. The journal's commitment to excellence is reflected in its competitive Scopus rankings, making it an essential resource for professionals and students alike who are keen to stay at the forefront of life sciences research.

Molecular Biomedicine

Connecting Research and Healthcare for a Healthier Tomorrow
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Molecular Biomedicine is a prestigious peer-reviewed journal published by SpringerNature, dedicated to advancing the fields of molecular biology and molecular medicine. With a commendable Q1 ranking in both categories for 2023, this journal stands out for its rigorous exploration of the biochemical processes underlying health and disease. Operating out of Germany, Molecular Biomedicine aims to provide comprehensive insights into cutting-edge research, facilitating interdisciplinary collaboration among researchers, healthcare professionals, and students alike. The journal's impact is reflected in its Scopus rankings, placing it in the upper echelons of the fields of biochemistry, genetics, and molecular biology. As an open access platform, it commits to disseminating knowledge widely, ensuring that pivotal discoveries are accessible to all. Researchers looking to publish in a dynamic environment that prioritizes innovation and application in the biomedical sciences will find Molecular Biomedicine an ideal outlet for their work.

Journal of Biomedical Research

Innovating Research, Transforming Medicine
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Advancing the Frontiers of Biological and Medical Research
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Cell Reports Medicine

Pioneering the future of healthcare with cutting-edge insights.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale

Connecting Researchers Through Open Access Knowledge
Publisher: PAGEPRESS PUBLISSN: 1826-8838Frequency: 2 issues/year

The Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale is a premier peer-reviewed journal published by PAGEPRESS PUBL, focusing on a diverse array of topics within the broad field of biological research. Established as an Open Access journal since 2009, it facilitates the dissemination of scientific knowledge across the globe, enhancing visibility and accessibility for researchers, professionals, and students alike. With an ISSN of 1826-8838 and E-ISSN 2284-0230, this journal serves as a platform for innovative studies in Biochemistry, Genetics, and Molecular Biology, with a growing emphasis on Plant Science. Although currently categorized in the Q4 quartile for various sub-disciplines, the journal is dedicated to fostering interdisciplinary collaboration and advancing research quality. The latest Scopus rankings indicate a burgeoning presence in the academic community, positioning itself at significant ranks within the fields it covers. With publication coverage extending from 2011 to 2024, the journal aims to push the frontiers of biological research while adapting to the evolving demands of the scientific community.